NCT04354376View on ClinicalTrials.gov

Replication of the TRANSCEND Antihypertensive Trial in Healthcare Claims Data

CompletedOBSERVATIONAL
Enrollment

40,048

Participants

Timeline

Start Date

September 22, 2017

Primary Completion Date

February 8, 2021

Study Completion Date

February 8, 2021

Conditions
Hypertension
Interventions
DRUG

Loop diuretics, thiazides, dihydropyridines

Loop diuretics, thiazides, or dihydropyridines dispensing claim is used as the reference

DRUG

Telmisartan

Telmisartan dispensing claim is used as the exposure

Trial Locations (1)

02120

Brigham And Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04354376 - Replication of the TRANSCEND Antihypertensive Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter